Key Highlights
- Jeffrey Elliott brings 20 years of leadership experience in medical diagnostics.
- Former CFO and COO of Exact Sciences Corp., driving high revenue growth and strategic acquisitions.
- Elliott joins at a pivotal time as Quanterix advances Alzheimer’s Disease testing infrastructure.
Source: Business Wire
Notable Quotes
- “We’re pleased to welcome Jeff to our board of directors at an exciting time for the company. As Quanterix actively builds the infrastructure for Alzheimer’s Disease testing to ensure access to early diagnosis, Jeff’s experience in scaling Exact Sciences’ operations and financial experience will be invaluable.” — Masoud Toloue, CEO at Quanterix
- “The mission to scale Quanterix’s Simoa technology is bold and ambitious, and I am excited to apply my experience to help the company achieve this goal and support continued innovation.” — Jeffrey Elliott, Board Member at Quanterix
SoHC's Take
The appointment of Jeffrey Elliott to Quanterix’s Board of Directors is a strategic move that positions the company for significant growth. Elliott’s extensive experience in scaling operations and driving revenue growth at Exact Sciences will be invaluable as Quanterix advances its pioneering Simoa technology and builds the infrastructure necessary for early Alzheimer’s Disease diagnosis. His background in both finance and business strategy, coupled with a deep understanding of the life sciences industry, will likely accelerate Quanterix’s growth trajectory and fortify its leadership in ultra-sensitive biomarker detection.
